1. Home
  2. GCMGW vs RVMDW Comparison

GCMGW vs RVMDW Comparison

Compare GCMGW & RVMDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCMGW
  • RVMDW
  • Stock Information
  • Founded
  • GCMGW 1971
  • RVMDW 2014
  • Country
  • GCMGW United States
  • RVMDW United States
  • Employees
  • GCMGW N/A
  • RVMDW N/A
  • Industry
  • GCMGW Finance/Investors Services
  • RVMDW
  • Sector
  • GCMGW Finance
  • RVMDW
  • Exchange
  • GCMGW Nasdaq
  • RVMDW Nasdaq
  • Market Cap
  • GCMGW N/A
  • RVMDW N/A
  • IPO Year
  • GCMGW N/A
  • RVMDW N/A
  • Fundamental
  • Price
  • GCMGW $2.42
  • RVMDW $0.10
  • Analyst Decision
  • GCMGW
  • RVMDW
  • Analyst Count
  • GCMGW 0
  • RVMDW 0
  • Target Price
  • GCMGW N/A
  • RVMDW N/A
  • AVG Volume (30 Days)
  • GCMGW 62.4K
  • RVMDW 15.6K
  • Earning Date
  • GCMGW 02-13-2025
  • RVMDW 02-26-2025
  • Dividend Yield
  • GCMGW N/A
  • RVMDW N/A
  • EPS Growth
  • GCMGW N/A
  • RVMDW N/A
  • EPS
  • GCMGW 0.03
  • RVMDW N/A
  • Revenue
  • GCMGW $514,011,999.00
  • RVMDW $742,000.00
  • Revenue This Year
  • GCMGW N/A
  • RVMDW N/A
  • Revenue Next Year
  • GCMGW N/A
  • RVMDW N/A
  • P/E Ratio
  • GCMGW $33.02
  • RVMDW N/A
  • Revenue Growth
  • GCMGW 15.79
  • RVMDW N/A
  • 52 Week Low
  • GCMGW $2.28
  • RVMDW $0.10
  • 52 Week High
  • GCMGW $2.50
  • RVMDW $0.12
  • Technical
  • Relative Strength Index (RSI)
  • GCMGW N/A
  • RVMDW N/A
  • Support Level
  • GCMGW N/A
  • RVMDW N/A
  • Resistance Level
  • GCMGW N/A
  • RVMDW N/A
  • Average True Range (ATR)
  • GCMGW 0.00
  • RVMDW 0.00
  • MACD
  • GCMGW 0.00
  • RVMDW 0.00
  • Stochastic Oscillator
  • GCMGW 0.00
  • RVMDW 0.00

About GCMGW GCM Grosvenor Inc.

GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.

About RVMDW Revolution Medicines Inc. Warrant

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

Share on Social Networks: